These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 19864537)

  • 1. Furthering our understanding of pathogen transmission in cystic fibrosis.
    Saiman L
    Thorax; 2009 Nov; 64(11):921-2. PubMed ID: 19864537
    [No Abstract]   [Full Text] [Related]  

  • 2. Segregation is not good for patients with cystic fibrosis.
    Geddes D
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S36-8. PubMed ID: 18607017
    [No Abstract]   [Full Text] [Related]  

  • 3. Water filters can prevent Stenotrophomonas maltophilia contamination of nebuliser equipment used by people with cystic fibrosis.
    Woodhouse R; Peckham DG; Conway SP; Denton M
    J Hosp Infect; 2008 Apr; 68(4):371-2. PubMed ID: 18353498
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucoid Inquilinus limosus in a young adult with cystic fibrosis.
    Hayes D; Murphy BS; Kuhn RJ; Anstead MI; Feola DJ
    Pediatr Pulmonol; 2009 Jun; 44(6):619-21. PubMed ID: 19434691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR.
    Atkinson RM; Lipuma JJ; Rosenbluth DB; Dunne WM
    J Clin Microbiol; 2006 Mar; 44(3):833-6. PubMed ID: 16517862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of cystic fibrosis patients with multi-drug resistant Gram-negative rods.
    Vonberg RP; Wolter A; Ziesing S; Gastmeier P
    Int J Hyg Environ Health; 2006 Jul; 209(4):333-6. PubMed ID: 16679060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging and unusual gram-negative infections in cystic fibrosis.
    Davies JC; Rubin BK
    Semin Respir Crit Care Med; 2007 Jun; 28(3):312-21. PubMed ID: 17562501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacterial infections of the lungs in mucoviscidosis patients].
    Hogardt M; Heesemann J
    MMW Fortschr Med; 2005 Jan; 147(4):38-40. PubMed ID: 15745340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia cepacia--a transmissible cystic fibrosis pathogen.
    Burns JL
    J Pediatr; 2001 Nov; 139(5):618-9. PubMed ID: 11713434
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis.
    Coenye T; Spilker T; Reik R; Vandamme P; Lipuma JJ
    J Clin Microbiol; 2005 Jul; 43(7):3463-6. PubMed ID: 16000479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.
    Wellinghausen N; Wirths B; Poppert S
    J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on antibiotics for infection control in cystic fibrosis.
    Kirkby S; Novak K; McCoy K
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):967-80. PubMed ID: 19803706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
    Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
    Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.
    Goss CH; Mayer-Hamblett N; Aitken ML; Rubenfeld GD; Ramsey BW
    Thorax; 2004 Nov; 59(11):955-9. PubMed ID: 15516471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First isolations of Segniliparus rugosus from patients with cystic fibrosis.
    Butler WR; Sheils CA; Brown-Elliott BA; Charles N; Colin AA; Gant MJ; Goodill J; Hindman D; Toney SR; Wallace RJ; Yakrus MA
    J Clin Microbiol; 2007 Oct; 45(10):3449-52. PubMed ID: 17670929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcaligenes infection in cystic fibrosis.
    Tan K; Conway SP; Brownlee KG; Etherington C; Peckham DG
    Pediatr Pulmonol; 2002 Aug; 34(2):101-4. PubMed ID: 12112775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbiological parameters of clinical interest in pulmonary infection in cystic fibrosis].
    Ballestero S; Escobar H; Suárez L; Baquero F
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):245-9. PubMed ID: 9044640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
    Saiman L; Chen Y; Tabibi S; San Gabriel P; Zhou J; Liu Z; Lai L; Whittier S
    J Clin Microbiol; 2001 Nov; 39(11):3942-5. PubMed ID: 11682511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.